US FDA approves Pfizer's Fragmin to treat paediatric patients with blood clots

The US Food and Drug Administration (FDA) approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous ... Lees verder

Bron:

Pharmamarketeer